Results 291 to 300 of about 9,409,354 (304)
Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression. [PDF]
Goel K +10 more
europepmc +1 more source
Autoimmune Diseases of the Eyelid Skin: Molecular Pathways, Clinical Manifestations, and Therapeutic Insights. [PDF]
Luboń W +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Ocular Pharmacology and Therapeutics, 2023
Losartan is an angiotensin II receptor blocker (ARB) that impedes transforming growth factor (TGF) beta signaling by inhibiting activation of signal transduction molecule extracellular signal-regulated kinase (ERK).
S. Wilson
semanticscholar +1 more source
Losartan is an angiotensin II receptor blocker (ARB) that impedes transforming growth factor (TGF) beta signaling by inhibiting activation of signal transduction molecule extracellular signal-regulated kinase (ERK).
S. Wilson
semanticscholar +1 more source
[Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study].
Klinische Monatsblätter für Augenheilkunde, 2002T. Reinhard +5 more
semanticscholar +1 more source
Roles of T-cells in the development of allergic conjunctival diseases.
Cornea, 2007A. Fukushima
semanticscholar +1 more source
Conjunctival Melanoma: Current Treatments and Future Options
American Journal of Clinical Dermatology, 2020Joseph M. Grimes +4 more
semanticscholar +1 more source
Tear osteopontin levels in patients with allergic conjunctival diseases
Graefe's Archive for Clinical and Experimental Ophthalmology, 2002E. Uchio +4 more
semanticscholar +1 more source
Penetrating keratoplasty in cicatrizing conjunctival diseases.
Ophthalmology (Rochester, Minn.), 1995Iknur Tugal-Tutkun, Y. Akova, C. Foster
semanticscholar +1 more source
Impression cytology with transfer in xerophtalmia and conjunctival diseases
International ophtalmology, 1992S. Resnikoff +3 more
semanticscholar +1 more source

